City Therapeutics
Facts
as of Nov 22, 2026City Therapeutics is a biopharmaceutical company developing RNA interference based medicines, including a Phase 1 clinical trial of CITY-FXI targeting thromboembolic diseases. Its job ads cover clinical pharmacology, toxicology, biometrics and corporate finance leaders. The company is based in Cambridge, Massachusetts, United States.
It is hiring: 13 open roles, 4 of them posted in the last 30 days.
- Headquarters
- Cambridge, United States
- Employees
- 51-200estimated range
- Listing
- NASDAQ: CTY
- Open roles
- 13Alion job postings
- Official records
- Wikidata Q140045857
- Website
- citytx.com
As of Nov 22, 2026, Alion lists 13 open roles at City Therapeutics. City Therapeutics is headquartered in Cambridge, United States. The median pay stated in its open roles is $200k, across 11 postings that state pay.
Funding
Full chapter →Funds reporting to the SEC (5) valued their City Therapeutics stock at $29.8M as of Jul 2026.
People
All open roles →13 open roles, 4 of them posted in the last 30 days.
Products
Products →City Therapeutics has 2 clinical trials on record, 2 under way.
Risk
Full record →City Therapeutics in public registers.
Footprint
Hiring in 1 city in 1 country.
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Cambridge United States | Headquarters | 12 | Biotech, Science & Research, Leadership | 25% |
Peers
Compare →Ranked #3 by open roles among its 11 closest peers.
| # | Company | HQ | Open roles | Size | |
|---|---|---|---|---|---|
| 1 | Beeline Medicines | Stamford, United States | 24 | 51-200 | |
| 2 | KymeraTx | Watertown, United States | 18 | 51-200 | |
| 3 | City Therapeutics | Cambridge, United States | 13 | 51-200 | |
| 4 | Wave Life Sciences | Cambridge, United States | 13 | 201-500 |
